Science 37

Access More Patients. Enroll Faster. Clinical Research that Works for Everyone™

[Science 37 @Science37x]

Science37 is redefining patient recruitment with a Direct-to-Patient (DTP) model that connects individuals to clinical studies—wherever they are.

👉 Learn more about the approach: https://t.co/LUSmN6jgel

#ClinicalTrials #PatientRecruitment #DecentralizedTrials

[Science 37 @Science37x]

Stay informed. Stay empowered. 🧠💙
At Science37, we’re committed to sharing valuable insights on a wide range of health conditions explored in our studies.

👉 Explore our articles: https://t.co/RYQ7LAWH7K

#Science37 #HealthInsights #ClinicalResearch

[Science 37 @Science37x]

Across all 50 states?

Our CMO, Dr. Debra Weinstein, was recently interviewed by—to share how Science 37’s Direct-to-Patient Site operates in practice.

Full interview here: https://t.co/LxKjW1JSdF

#ClinicalResearch #ClinicalTrials #ClinicalStudies #Healthcare

[Science 37 @Science37x]

🎤 Join Kelly McKee at the OECT Summit for a session on 𝘛𝘩𝘦 𝘌𝘷𝘰𝘭𝘶𝘵𝘪𝘰𝘯 𝘰𝘧 𝘵���𝘦 𝘔𝘰𝘥𝘦𝘳𝘯 𝘊𝘭𝘪𝘯𝘪𝘤𝘢𝘭 𝘛𝘳𝘪𝘢𝘭 𝘚𝘪𝘵𝘦. We can't wait!

📅 Thursday, April 16 | 9:50 am ET
📍 DoubleTree by Hilton Philadelphia Airport

#ClinicalTrials #OECTSummit

[Science 37 @Science37x]

These innovations are opening new doors for progress and access.

🔬Learn how decentralized trials are impacting rare disease research and what this means for the future of care. 👉 https://t.co/ZME8H2AnsQ

#RareDisease #ClinicalResearch #DecentralizedTrials #HealthcareInnovation

[Science 37 @Science37x]

When Lucas’s parents learned about a clinical study for Fragile X Syndrome, they faced a common dilemma. With another son in school and a 5-hour trek to the nearest participating site, site visits were impossible.
https://t.co/9C22A8zxYC

#ClinicalTrials #Pediatrics #FragileX

[Science 37 @Science37x]

A couple of weeks ago, we shared the launch of Science 37's Pediatrics Department—a milestone designed to move research forward by meeting families exactly where they are.

🧸 Read the announcement here: https://t.co/8PLIcExXWP

#PediatricResearch #Pediatrics

[Science 37 @Science37x]

In this 20-minute episode, Tyler Van Horn, CEO at Science 37, explains how we've flipped the script with our Direct-to-Patient Site. Imagine a single site that covers all 50 states by bringing the trial to the patient’s living room.

🎧 Play the episode: https://t.co/3YixNEJ0Pf

[Science 37 @Science37x]

🎥 See the Future of Clinical Trials in Action

Discover how Science 37 is transforming research with its Direct-to-Patient model—bringing studies to participants, increasing access, and accelerating results.

👉 Watch the video now to learn more:
https://t.co/8N8n5kJOy8

[Science 37 @Science37x]

GLP-1 agonists are reshaping the future of metabolic and heart health.

💊 Learn how GLP-1 agonists are transforming treatment and what it means for the future of care.
👉 https://t.co/yyC4lO5uPr

#GLP1 #MetabolicHealth #HeartHealth #ClinicalResearch #Science37Cares

[Science 37 @Science37x]

Today, we are spotlighting some of our Research-Grade Nurses who power Science 37’s Pediatrics Department. 🧸
To learn more about how Science 37 supports pediatric research, visit our department page: https://t.co/qX99qVvd5S

[Science 37 @Science37x]

Pediatric clinical research is entering a new era — Explore how pediatric clinical research is evolving and what this shift means for the future of care.
👉 Read the full article: https://t.co/yQpUdSxxrN

#ClinicalResearch #Pediatrics #HealthcareInnovation #PatientAccess

[Science 37 @Science37x]

Lennox-Gastaut Syndrome (LGS) affects more than just seizure. Learn how LGS impacts cognition and behavior and explore ways to better manage these challenges.
👉 Read the full article: https://t.co/ZZ0ZCO0LHn

#LGS #EpilepsyAwareness #RareDisease #Science37Cares

[Science 37 @Science37x]

Science 37 announced the formal launch of its dedicated 𝗣𝗲𝗱𝗶𝗮𝘁𝗿𝗶𝗰𝘀 𝗗𝗲𝗽𝗮𝗿𝘁𝗺𝗲𝗻𝘁, reinforcing the company’s commitment to advancing pediatric research.
🧸 Read the full announcement: https://t.co/tIgrMvIMZ2

#ClinicalTrials #PediatricResearch #Pediatrics #News

[Science 37 @Science37x]

🧸 We’ve been working on something special for our youngest participants.

For too long, the industry has asked families to fit research into their lives. At Science 37,
we’re fitting clinical research into families' lives.
Stay tuned tomorrow for an exciting announcement...

[Science 37 @Science37x]

Explore the latest breakthroughs in Dravet Syndrome research and what they mean for the future of care.
👉 Read the full article: https://t.co/d78VNiIfbO

#DravetSyndrome #EpilepsyResearch #RareDisease #HealthcareInnovation #Science37Cares

[Science 37 @Science37x]

GLP-1 treatments are evolving — from injectable pens to new oral weight-loss pills. Which option could be right for patients?

#GLP1 #WeightLossTreatment #Science37Cares

[Science 37 @Science37x]

The team had a great time in Orlando at Modern Nurse Fest!

A big thank you to everyone who joined the session and stopped by to connect. We loved meeting so many passionate nurses and healthcare professionals! 💙

#ClinicalResearch #HealthcareInnovation #Science37Cares

[Science 37 @Science37x]

📍 𝗢𝘂𝗿 𝘁𝗲𝗮𝗺 𝗶𝘀 𝗵𝗲𝗮𝗱𝗶𝗻𝗴 𝘁𝗼 hashtag#𝗢𝗖𝗧𝗦𝗼𝘂𝘁𝗵𝗲𝗮𝘀𝘁 𝗶𝗻 𝗥𝗧𝗣!

Stop by Booth #5 to connect with us!

Or, schedule a meeting here: https://t.co/zo1f5a5hnJ
hashtag#ClinicalResearch hashtag#ClinicalTrials hashtag#OCT

[Science 37 @Science37x]

GLP-1 treatments are evolving quickly — from traditional injections to new oral options.

👉 Learn more about the changing landscape of GLP-1 treatments:
https://t.co/1F6RULicAV

#GLP1 #ClinicalResearch #HealthcareInnovation #Science37Cares